COST-EFFECTIVENESS OF ALTEPLASE TO TREAT ACUTE ISCHEMIC STROKE WITHIN 4.5 HOURS AFTER ONSET IN THE BRAZILIAN UNIFIED HEALTH SYSTEM PERSPECTIVE

被引：0
|
作者：
Campos, D. B. [1 ]
Martins, S. O. [2 ]
Safanelli, J. [3 ]
Santoni, N. B. [4 ]
Marcolino, M. [5 ]
Antonini Ribeiro, R. [6 ]
机构：
[1] Boehringer Ingelheim Brazil, Sao Paulo, Brazil
[2] Hosp Moinhos de Vento, Porto Alegre, RS, Brazil
[3] Joinville Stroke Registry, Joinville, Brazil
[4] Boehringer Ingelheim GmbH & Co KG, Sao Paulo, Brazil
[5] Univ Fed Rio Grande do Sul, Porto Alegre, RS, Brazil
[6] HTAnalyze, Porto Alegre, RS, Brazil
来源：
VALUE IN HEALTH | 2020年 / 23卷
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PND26
引用
收藏
页码：S626 / S627
页数：2
相关论文
共 50 条
  • [31] Cost-effectiveness of mechanical thrombectomy for acute ischemic stroke: an Australian payer perspective
    Arora, Nimita
    Makino, Koji
    Tilden, Dominic
    Lobotesis, Kyriakos
    Mitchell, Peter
    Gillespie, John
    JOURNAL OF MEDICAL ECONOMICS, 2018, 21 (08) : 799 - 809
  • [32] Intravenous Fibrinolysis 3 to 4.5 Hours after Acute Ischemic Stroke Onset: A Single Institution Experience
    Alderazi, Yazan
    Yang, Julian
    Teleb, Mohamed
    Chang, Jason
    Awad, Alwala
    Frey, James
    Restrepo, Lucas
    NEUROLOGY, 2010, 74 (09) : A446 - A446
  • [33] Alteplase at 0.6 mg/kg for acute ischemic stroke within 3 hours of onset - Japan Alteplase Clinical Trial (J-ACT)
    Yamaguchi, Takenori
    Mori, Etsuro
    Minematsu, Kazuo
    Nakagawara, Jyoji
    Hashi, Kazuo
    Saito, Isamu
    Shinohara, Yukito
    STROKE, 2006, 37 (07) : 1810 - 1815
  • [34] Impact of Protocol Deviations in Acute Ischemic Stroke Treated With Intravenous rt-PA Within 4.5 Hours After Symptom Onset
    Alderazi, Y. J.
    Chang, J.
    Yang, J. P.
    Teleb, M.
    Chapple, K.
    Awad, A.
    Restrepo, Lucas
    NEUROHOSPITALIST, 2012, 2 (03): : 82 - 86
  • [35] Different doses of tenecteplase vs. alteplase for acute ischemic stroke within 4.5 hours of symptom onset: a network meta-analysis of randomized controlled trials
    Liang, Huo
    Wang, Xue
    Quan, Xuemei
    Chen, Shijian
    Qin, Bin
    Liang, Shuolin
    Huang, Qiuhui
    Zhang, Jian
    Liang, Zhijian
    FRONTIERS IN NEUROLOGY, 2023, 14
  • [36] Cost-Effectiveness of Recombinant Tissue-Type Plasminogen Activator Within 3 Hours of Acute Ischemic Stroke Current Evidence
    Boudreau, Denise M.
    Guzauskas, Gregory F.
    Chen, Er
    Lalla, Deepa
    Tayama, Darren
    Fagan, Susan C.
    Veenstra, David L.
    STROKE, 2014, 45 (10) : 3032 - 3039
  • [37] COST-EFFECTIVENESS OF COMBINED TREATMENT WITH ALTEPLASE (RT-PA) AND CEREBROLYSIN IN ACUTE ISCHEMIC HEMISPHERIC STROKE IN AUSTRIA
    Walter, E.
    Bauer, M.
    Ressl, S.
    VALUE IN HEALTH, 2015, 18 (07) : A390 - A390
  • [38] CT Hypoperfusion-Hypodensity Mismatch to Identify Patients With Acute Ischemic Stroke Within 4.5 Hours of Symptom Onset
    Sporns, Peter B.
    Kemmling, Andre
    Minnerup, Heike
    Meyer, Lennart
    Krogias, Christos
    Puetz, Volker
    Thierfelder, Kolja
    Duering, Marco
    Kaiser, Daniel
    Langner, Soenke
    Massoth, Christina
    Brehm, Alex
    Rotkopf, Lukas
    Kunz, Wolfgang G.
    Karch, Andre
    Fiehler, Jens
    Heindel, Walter
    Schramm, Peter
    Royl, Georg
    Wiendl, Heinz
    Psychogios, Marios
    Minnerup, Jens
    NEUROLOGY, 2021, 97 (21) : E2088 - E2095
  • [39] SAFETY, EFFECTIVENESS, AND PRACTICALITY OF ENDOVASCULAR THERAPY WITHIN THE FIRST 3 HOURS OF ACUTE ISCHEMIC STROKE ONSET
    Mathews, Marlon S.
    Sharma, Jitendra
    Snyder, Kenneth V.
    Natarajan, Sabareesh K.
    Siddiqui, Adnan H.
    Hopkins, L. Nelson
    Levy, Elad I.
    NEUROSURGERY, 2009, 65 (05) : 860 - 865
  • [40] Optimal Transport System for Acute Ischemic Stroke Patients: A Cost-Effectiveness Analysis
    Morii, Yasuhiro
    Osanai, Toshiya
    Fujiwara, Kensuke
    Tani, Yuji
    Takamiya, Soichiro
    Tanikawa, Takumi
    Ogasawara, Katsuhiko
    MEDINFO 2023 - THE FUTURE IS ACCESSIBLE, 2024, 310 : 1558 - 1559
12345